Blackstone Inc
ATXS

Blackstone Inc’s Astria Therapeutics ATXS Stock Holding History

Blackstone Inc’s Portfolio ATXS Stock Details ATXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-33,470
Closed -$1.29M – 173
2020
Q2 		$1.29M Hold
33,470
– – 0.01% 132
2020
Q1 		$833K Hold
33,470
– – 0.01% 71
2019
Q4 		$1.19M Hold
33,470
– – 0.01% 59
2019
Q3 		$1.08M Hold
33,470
– – 0.01% 61
2019
Q2 		$1.62M Hold
33,470
– – 0.01% 75
2019
Q1 		$1.59M Hold
33,470
– – 0.01% 65
2018
Q4 		$878K Buy
+33,470
New +$1.27M 0.01% 47

Other funds holding ATXS

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return